SG11201602066RA - Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparation - Google Patents
Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparationInfo
- Publication number
- SG11201602066RA SG11201602066RA SG11201602066RA SG11201602066RA SG11201602066RA SG 11201602066R A SG11201602066R A SG 11201602066RA SG 11201602066R A SG11201602066R A SG 11201602066RA SG 11201602066R A SG11201602066R A SG 11201602066RA SG 11201602066R A SG11201602066R A SG 11201602066RA
- Authority
- SG
- Singapore
- Prior art keywords
- choline
- derivatives
- compositions
- processes
- preparation
- Prior art date
Links
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 title 1
- 229960001231 choline Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361893307P | 2013-10-21 | 2013-10-21 | |
US201361893308P | 2013-10-21 | 2013-10-21 | |
PCT/IL2014/050912 WO2015059697A1 (en) | 2013-10-21 | 2014-10-21 | Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201602066RA true SG11201602066RA (en) | 2016-04-28 |
Family
ID=51999472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201602066RA SG11201602066RA (en) | 2013-10-21 | 2014-10-21 | Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparation |
Country Status (11)
Country | Link |
---|---|
US (1) | US20160243061A1 (en) |
EP (1) | EP3060202A1 (en) |
JP (1) | JP2016535734A (en) |
KR (1) | KR20160075524A (en) |
CN (1) | CN105682481A (en) |
AU (1) | AU2014338503A1 (en) |
HK (1) | HK1222336A1 (en) |
IL (1) | IL244484A0 (en) |
MX (1) | MX2016003207A (en) |
SG (1) | SG11201602066RA (en) |
WO (1) | WO2015059697A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3285602A1 (en) * | 2015-04-21 | 2018-02-28 | Enzymotec Ltd. | Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparation |
CN108813628A (en) * | 2018-05-23 | 2018-11-16 | 青岛大学 | A kind of preparation method preventing and treating Parkinson's disease edible composition |
CN108813453A (en) * | 2018-05-23 | 2018-11-16 | 青岛大学 | A kind of edible composition for preventing and treating Parkinson's disease |
US20210212936A1 (en) * | 2018-06-01 | 2021-07-15 | Baxter International Inc. | Parenteral nutrition formulation |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2864848A (en) | 1954-07-19 | 1958-12-16 | Ca Nat Research Council | Method of producing l-alpha-glycerylphosphorylcholine |
US3475177A (en) * | 1966-02-09 | 1969-10-28 | Commercial Solvents Corp | Choline composition |
JPS62111926A (en) * | 1985-11-11 | 1987-05-22 | Nippon Oil & Fats Co Ltd | Cholinergic nervous system activator |
JPH0656671A (en) * | 1992-08-04 | 1994-03-01 | Nippon Oil & Fats Co Ltd | Functional food |
CN1115217A (en) * | 1994-07-22 | 1996-01-24 | 戴根春 | Prodn. method for egg health products |
US6013273A (en) * | 1997-01-27 | 2000-01-11 | Novartis Nutrition Ag | Treatment of endotoxic shock |
US20040043013A1 (en) * | 2000-12-28 | 2004-03-04 | Mccleary Edward Larry | Metabolic uncoupling therapy |
US20030206881A1 (en) * | 2001-05-31 | 2003-11-06 | Peter Fussbroich | Phospholipidic composition as well as the use thereof |
EP1875816A3 (en) * | 2003-07-10 | 2008-03-12 | Carl A. Forest | Beverages with specialized supplements |
JP4933432B2 (en) | 2005-07-19 | 2012-05-16 | 旭化成ファーマ株式会社 | New phospholipid processing agent |
JP5300186B2 (en) * | 2006-08-23 | 2013-09-25 | 株式会社明治 | Milk-derived composition for pregnant women that suppresses increase in homocysteine concentration in blood |
EP2076244B1 (en) * | 2006-10-10 | 2016-12-07 | Jina Pharmaceuticals Inc. | Aqueous systems for the preparation of lipid-based pharmaceutical compounds; compositions, methods, and uses thereof |
CA2609580A1 (en) * | 2006-12-06 | 2008-06-06 | H3 Formulations Ltd. | Composition for promoting cognitive attributes |
JP2009155337A (en) * | 2009-03-31 | 2009-07-16 | Tsujido Chemical Corp | Treating agent |
JP6043064B2 (en) * | 2009-06-16 | 2016-12-14 | 株式会社明治 | A milk-derived composition for pregnant women that prevents the risk of reduced birth weight in babies |
WO2012090713A1 (en) * | 2010-12-29 | 2012-07-05 | 株式会社西崎創薬研究所 | Concomitant drug for improving cognitive function |
ITGE20110050A1 (en) * | 2011-04-29 | 2012-10-30 | Marco Zipoli | FOOD, IN PARTICULAR A DRINK FOR HUMAN CONSUMPTION |
CN102516292B (en) * | 2011-11-08 | 2014-09-10 | 西北大学 | Natural L-alpha-glycerophosphocholine (GPC) and preparation method thereof |
CN102964377B (en) * | 2012-11-30 | 2015-05-27 | 西北大学 | Method for preparing natural L-alpha-glycerol phosphatidylcholine |
EP2859889A1 (en) * | 2013-10-14 | 2015-04-15 | Abbott Laboratories | Compositions and methods for improving cognitive function |
-
2014
- 2014-10-21 JP JP2016525941A patent/JP2016535734A/en active Pending
- 2014-10-21 SG SG11201602066RA patent/SG11201602066RA/en unknown
- 2014-10-21 WO PCT/IL2014/050912 patent/WO2015059697A1/en active Application Filing
- 2014-10-21 EP EP14805361.4A patent/EP3060202A1/en not_active Withdrawn
- 2014-10-21 MX MX2016003207A patent/MX2016003207A/en unknown
- 2014-10-21 CN CN201480050510.8A patent/CN105682481A/en active Pending
- 2014-10-21 US US15/029,878 patent/US20160243061A1/en not_active Abandoned
- 2014-10-21 AU AU2014338503A patent/AU2014338503A1/en not_active Abandoned
- 2014-10-21 KR KR1020167010400A patent/KR20160075524A/en not_active Application Discontinuation
-
2016
- 2016-03-08 IL IL244484A patent/IL244484A0/en unknown
- 2016-09-06 HK HK16110609.4A patent/HK1222336A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
HK1222336A1 (en) | 2017-06-30 |
IL244484A0 (en) | 2016-04-21 |
US20160243061A1 (en) | 2016-08-25 |
EP3060202A1 (en) | 2016-08-31 |
WO2015059697A1 (en) | 2015-04-30 |
CN105682481A (en) | 2016-06-15 |
MX2016003207A (en) | 2016-08-11 |
KR20160075524A (en) | 2016-06-29 |
AU2014338503A1 (en) | 2016-03-31 |
JP2016535734A (en) | 2016-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL285390A (en) | Arylquinazolines, their preparation and pharmaceutical compositions containing them | |
IL288961A (en) | Pharmaceutical compositions | |
IL243752B (en) | Multispecific antibodies, compositions comprising same and uses thereof | |
IL241355A0 (en) | Pyrazole-amide compounds, compositions comprising same and uses yhereof | |
PL2943181T3 (en) | Pharmaceutical compositions | |
HK1222563A1 (en) | Pharmaceutical composition, preparation and uses thereof | |
HK1210806A1 (en) | Method for manufacturing immunocyte-containing composition, and cancer-treating composition | |
ZA201408333B (en) | Pharmaceutical compositions | |
IL246406A0 (en) | Imidazopyrazinone derivatives, their preparation and pharmaceutical compositions containing them | |
HK1216839A1 (en) | Modified release formulation | |
EP2941418A4 (en) | N1-cyclic amine-n5-substituted biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same | |
HK1222336A1 (en) | Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparation | |
IL233682A0 (en) | Substituted phenylazole derivatives, compositions comprising same and uses thereof | |
IL239873B (en) | Piperidinylcarbazole derivatives, their preparation and pharmaceutical compositions containing them | |
IL239874A0 (en) | Acylguanidine derivatives, their preparation and pharmaceutical compositions containing them | |
HRP20171888T1 (en) | Pharmaceutical compositions | |
EP3057972A4 (en) | Novel compositions, uses and methods for their preparation | |
EP2945703A4 (en) | Formulations of albu-bche, preparation and uses thereof | |
IL284405A (en) | Pharmaceutical composition, preparation and uses thereof | |
GB201304699D0 (en) | Pharmaceutical compositions | |
GB201321497D0 (en) | Pharmaceutical compositions | |
GB201312851D0 (en) | Pharmaceutical compositions |